Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...

A panelist discusses how she navigates the economic challenges of neurokinin-targeted therapies by working with insurance ...

In a partisan vote, the Senate Finance Committee voted to forward the nomination of Robert F. Kennedy Jr. as HHS Secretary to the full Senate ...

Becky Kamowitz was appointed executive director of The Skin Cancer Foundation in January 2025. She talks about the ...

This follows the company’s recent earnings call, where executives discussed the organization’s growth and future plans, ...

Potential threats to HIV care and fallout over the next four years, according to Jose Abrigo, Esq., HIV project director at ...

Much of the association between trauma and suicide risk among university students can be explained by shame, a new study ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.